Applied Molecular Transport Inc. Common Stock
AMTI
AMTI was delisted on the 26th of December, 2023.
35 hedge funds and large institutions have $6.39M invested in Applied Molecular Transport Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 13 reducing their positions, and 9 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
19% less funds holding
Funds holding: 43 → 35 (-8)
19% less capital invested
Capital invested by funds: $7.85M → $6.39M (-$1.46M)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
85% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$223K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$9.36K |
| 3 |
Goldman Sachs
New York
|
+$6.21K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$172K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$168K |
| 3 |
Renaissance Technologies
New York
|
-$152K |
| 4 |
Millennium Management
New York
|
-$60.9K |
| 5 |
MCM
Moore Capital Management
New York
|
-$42K |
AMTI Hedge Fund Activity: Q1 2023 in Review
35 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Applied Molecular Transport Inc. Common Stock (AMTI) for Q1 2023, worth a combined $6.39M — down 19% from $7.85M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of AMTI and 2 opened new positions — a net loss of 7 holders — while 13 trimmed existing stakes and 2 added.
The largest buyer was Morgan Stanley, adding an estimated $223K. The largest seller was Franklin Resources, exiting entirely with an estimated $172K sold.
- 35 institutional investors held Applied Molecular Transport Inc. Common Stock (AMTI) as of Q1 2023, down from 43 in Q4 2022.
- Funds reported $6.39M of Applied Molecular Transport Inc. Common Stock stock for Q1 2023, down 19% quarter-over-quarter.
- 2 funds opened new Applied Molecular Transport Inc. Common Stock positions in Q1 2023 and 9 closed out, a net change of -7 holders.
- The largest Applied Molecular Transport Inc. Common Stock buyer in Q1 2023 was Morgan Stanley, an estimated $223K added.
- The largest Applied Molecular Transport Inc. Common Stock seller in Q1 2023 was Franklin Resources, an estimated $172K sold.
Based on aggregated 13F filings for Q1 2023.